IV Drips Are Expensive And Time Consuming. Stable NAD+ Was Only Available By IV, Until Now
NAD+ is a notoriously unstable molecule. It oxidizes and degrades quickly outside controlled conditions, which is exactly why stable NAD+ has historically only existed inside IV drip clinics.
HINNAO's patented high-stability liposome technology encapsulates and stabilizes each lipid particle inside a phospholipid-based MCT carrier system, protecting the molecule from oxidation long before it ever reaches your mouth.
What used to require a clinic setting can now be held under your tongue at your kitchen counter.
Clinic-grade stability, without the clinic.



